Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Autoimmune & immunology R&D Pipeline

Autoimmune, rheumatology, and immunology biologics in clinical development.

Programs 985

Quick answer

Autoimmune & immunology: NovaPharmaNews indexes 985 autoimmune & immunology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Autoimmune, rheumatology, and immunology biologics in clinical development.

Top sponsors

Pipeline programs

Page 12 of 21

  1. Jueyin granules

    The First People's Hospital of Lianyungang

    Psoriasis Vulgaris

    phase 2 small molecule active

    1 trial

  2. Jueyin granules

    Universal Integrated

    Plaque Psoriasis

    phase 2 small molecule active

    1 trial

  3. KPL-404

    Kiniksa Pharmaceuticals International, plc

    Arthritis, Rheumatoid

    phase 2 small molecule completed

    1 trial

  4. KYV-101 anti-CD19 CAR-T cell therapy

    Kyverna Therapeutics

    Lupus Nephritis

    phase 2 mab active

    2 trials

  5. KYV101

    Kyverna Therapeutics

    Rheumatoid Arthritis

    phase 2 small molecule active

    1 trial

  6. KYV101-003

    Kyverna Therapeutics

    Lupus Nephritis

    phase 2 other active

    1 trial

  7. LEO 90105

    LEO Pharma A/S

    Psoriasis Vulgaris

    phase 2 small molecule completed

    1 trial

  8. LNA043

    Novartis Pharmaceuticals

    Osteoarthritis

    phase 2 small molecule active

    1 trial

  9. LX3305 low dose

    LEXICON PHARMACEUTICALS, INC.

    Rheumatoid Arthritis

    phase 2 small molecule completed

    1 trial

  10. LY3471851

    Nektar Therapeutics UK Limited

    Systemic Lupus Erythematosus

    phase 2 small molecule completed

    2 trials

  11. LY3471851

    Nektar Therapeutics UK Limited

    Colitis, Ulcerative

    phase 2 small molecule terminated

    1 trial

  12. LY3871801

    RIGEL PHARMACEUTICALS INC

    Rheumatoid Arthritis

    phase 2 small molecule completed

    1 trial

  13. LY4268989

    Eli Lilly and Company

    Ulcerative Colitis (UC)

    phase 2 small molecule active

    1 trial

  14. Lanraplenib

    Lakefront Biotherapeutics NV

    Cutaneous Lupus Erythematosus

    phase 2 small molecule completed

    1 trial

  15. Laquinimod

    Teva Pharma GmbH

    Lupus Nephritis

    phase 2 small molecule completed

    1 trial

  16. Laquinimod

    Teva Pharma GmbH

    Lupus Arthritis

    phase 2 small molecule completed

    1 trial

  17. Laquinimod

    Teva Pharma GmbH

    Crohn's Disease

    phase 2 small molecule completed

    1 trial

  18. Leflunomide

    Sanofi Pasteur

    Systemic Lupus Eythematosus (SLE)

    phase 2 small molecule completed

    1 trial

  19. Leukocyte-Poor Platelet Rich Plasma (LP-PRP)

    United Therapeutics Europe Ltd

    Osteoarthritis, Knee

    phase 2 mab active

    1 trial

  20. Losartan

    United Therapeutics Europe Ltd

    Hip Osteoarthritis

    phase 2 small molecule terminated

    1 trial

  21. M23-703

    AbbVie Deutschland GmbH & Co. KG

    Ulcerative Colitis

    phase 2 small molecule active

    1 trial

  22. M24-885

    AbbVie Deutschland GmbH & Co. KG

    Moderate to Severe Crohn’s Disease

    phase 2 small molecule active

    1 trial

  23. M25-056

    AbbVie Deutschland GmbH & Co. KG

    Rheumatoid Arthritis

    phase 2 small molecule active

    1 trial

  24. M5049 low dose

    Merck KGaA, Darmstadt, Germany

    Systemic Lupus Erythematosus

    phase 2 small molecule active

    1 trial

  25. MK-6194

    Merck KGaA, Darmstadt, Germany

    Systemic Lupus Erythematosus

    phase 2 mab terminated

    1 trial

  26. MOL4239

    Moleculin Biotech

    Psoriasis

    phase 2 small molecule completed

    1 trial

  27. MS200569_0003

    Merck Sharp and Dohme

    Systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE)

    phase 2 small molecule active

    1 trial

  28. Maraviroc

    Pfizer

    Arthritis, Rheumatoid

    phase 2 small molecule terminated

    1 trial

  29. Match placebo to test product, Balinatunfib

    Sanofi-aventis Healthcare Pty Ltd

    Crohn's disease

    phase 2 small molecule active

    1 trial

  30. Mesenchymal progenitor cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Knee Osteoarthritis

    phase 2 mab completed

    1 trial

  31. Micronized DHACM 40 mg

    United Therapeutics Europe Ltd

    Knee Osteoarthritis

    phase 2 mab terminated

    1 trial

  32. Mirikizumab - Intravenous (IV)

    Eli Lilly and Company

    Colitis, Ulcerative

    phase 2 small molecule active

    1 trial

  33. Mosunetuzumab

    Hoffmann-La Roche

    Systemic Lupus Erythematosus (SLE) With or Without Active Lupus Nephritis (LN)

    phase 2 small molecule active

    1 trial

  34. NDI-034858

    Takeda

    Psoriatic Arthritis

    phase 2 small molecule completed

    1 trial

  35. NDI-034858 study drug

    Takeda

    Moderate to Severe Plaque Psoriasis

    phase 2 small molecule completed

    1 trial

  36. NKTR-181

    Nektar Therapeutics UK Limited

    Osteoarthritis of the Knee

    phase 2 small molecule completed

    1 trial

  37. NMD670-02-0002

    Lacuna Pharma Pty Ltd

    Myasthenia Gravis

    phase 2 small molecule active

    1 trial

  38. Namilumab

    Takeda

    Rheumatoid Arthritis

    phase 2 small molecule completed

    2 trials

  39. Namilumab

    Takeda

    Plaque Psoriasis

    phase 2 small molecule completed

    1 trial

  40. Natrunix

    XBiotech Germany GmbH

    Rheumatoid Arthritis

    phase 2 small molecule completed

    1 trial

  41. Natrunix 400 mg

    XBiotech Germany GmbH

    Rheumatoid Arthritis

    phase 2 mab active

    1 trial

  42. Natrunix with MTX placebo (+folate)

    XBiotech Germany GmbH

    Rheumatoid Arthritis

    phase 2 small molecule active

    1 trial

  43. Not the same excipients as Test, Balinatunfib

    Sanofi-aventis Healthcare Pty Ltd

    Colitis Ulcerative

    phase 2 small molecule active

    1 trial

  44. OD-07656

    Odyssey Therapeutics

    Ulcerative Colitis (UC)

    phase 2 small molecule active

    1 trial

  45. OD-07656-201

    Odyssey Therapeutics

    Moderately to Severely Active Ulcerative Colitis

    phase 2 small molecule active

    1 trial

  46. OPRX-106

    Protalix BioTherapeutics

    Ulcerative Colitis

    phase 2 small molecule active

    1 trial

  47. ORKA-001

    Oruka Therapeutics

    Plaque Psoriasis

    phase 2 small molecule active

    2 trials

  48. ORKA-001 Induction Dose

    Oruka Therapeutics

    Plaque Psoriasis

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many autoimmune & immunology pipeline programs are tracked?

985 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.